A GnRH agonist and exogenous hormone stimulation protocol has a higher live-birth rate than a natural endogenous hormone protocol for frozen-thawed blastocyst-stage.

Slides:

Advertisements

Similar presentations

The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis

Advertisements

Krinos M. Trokoudes, M. D. , Constantinos Pavlides, M. Sc

Demián Glujovsky, M.D., M.Sc., Cynthia Farquhar, M.D., M.P.H.

Are good patient and embryo characteristics protective against the negative effect of elevated progesterone level on the day of oocyte maturation? Micah.

Quality of life and psychosocial and physical well-being among 1,023 women during their first assisted reproductive technology treatment: secondary outcome.

Is the effect of premature elevated progesterone augmented by human chorionic gonadotropin versus gonadotropin-releasing hormone agonist trigger? Matthew.

Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection.

Single blastocyst transfer: a prospective randomized trial

Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing.

Obstetric and perinatal outcomes after either fresh or thawed frozen embryo transfer: an analysis of 112,432 singleton pregnancies recorded in the Human.

Elective single embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics

Endometrin as luteal phase support in assisted reproduction

The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated.

Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D. Fertility and Sterility

Trophectoderm grade predicts outcomes of single-blastocyst transfers

A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study Nicole Hope, M.B., B.S., Hon., Luk.

Is frozen embryo transfer cycle associated with a significantly lower incidence of ectopic pregnancy? An analysis of more than 30,000 cycles Bo Huang,

Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for.

Initial experience with a risk-sharing in vitro fertilization–embryo transfer program with novel features Jacques P. Stassart, M.D., Romaine B. Bayless,

Examining the temperature of embryo culture in in vitro fertilization: a randomized controlled trial comparing traditional core temperature (37°C) to.

The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.

Lindsay Kroener, M. D. , Gayane Ambartsumyan, M. D. , Ph. D

Iris G. Insogna, M. D. , Malinda S. Lee, M. D. , M. B. A. , Rebecca M

Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D.

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

G. Ambartsumyan, M. Surrey, H. Danzer, D. Hill Fertility and Sterility

Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis

Oocyte cryopreservation

Prevalence of premature urinary luteinizing hormone surges in women with regular menstrual cycles and its effect on implantation of frozen-thawed embryos

Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain Mohamed A. Bedaiwy,

Influence of acupuncture stimulation on pregnancy rates for women undergoing embryo transfer Caroline Smith, Ph.D., Meaghan Coyle, B.Hlth.Sc. (Acup.),

Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial Robert Boostanfar, M.D.,

I. Dimitriadis, G. Y. Christou, K. A. Dickinson, M. Thatcher, C. L

Initial IVF-ET experience with assisted hatching performed 3 days after retrieval followed by day 5 embryo transfer Margaret C. Graham, M.S., Kathleen.

Dmitry M. Kissin, M. D. , M. P. H. , Jennifer F. Kawwass, M. D

Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose.

A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin.

The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis

Fewer than 9 days of estrogen exposure prior to progesterone initiation results in lower pregnancy rates in programmed frozen embryo transfer cycles

Nigel Pereira, M. D. , Hency H. Patel, B. S. , Logan D. Stone, B. A

Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic.

Programming the endometrium for deferred transfer of cryopreserved embryos: hormone replacement versus modified natural cycles Eva R. Groenewoud, M.D.,

How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis Dimitra Kyrou,

Does a frozen embryo transfer ameliorate the effect of elevated progesterone seen in fresh transfer cycles? Mae Wu Healy, D.O., George Patounakis, M.D.,

Should embryos developing to blastocysts on day 7 be cryopreserved and transferred: an analysis of pregnancy and implantation rates George Kovalevsky,

Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis Aylin Pelin Cil, M.D., Heejung Bang, Ph.D.,

Pregnancy outcomes from more than 1,800 in vitro fertilization cycles with the use of 24- chromosome single-nucleotide polymorphism–based preimplantation.

Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction–intrauterine insemination to in vitro.

Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting Basil Ho Yuen, M.B., Ch.B., Tuan-Anh.

Tal Imbar, M.D., Arye Hurwitz, M.D. Fertility and Sterility

Aaron K. Styer, M. D. , Diane L. Wright, Ph. D. , H. C. L. D. , Anne M

Live babies born per oocyte retrieved in a subpopulation of oocyte donors with repetitive reproductive success J. Ryan Martin, M.D., Jason G. Bromer,

Dizygotic twin delivery following in vitro fertilization and transfer of thawed blastocysts cryopreserved at day 6 and 7 E.Scott Sills, M.D., Cindy L.

Bruce S Shapiro, M. D. , Kevin S Richter, Ph. D. , Dee C Harris, M. T

S. Samuel Kim, M.D. Fertility and Sterility

Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study Richard.

Yoko Kumasako, B. E. , Eiko Otsu, M. En. , Takafumi Utsunomiya, M. D

Eric S. Surrey, M. D. , Debra A. Minjarez, M. D. , John M. Stevens, B

Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr Murat Arslan, M.D.,

Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery.

Transfer of two versus three embryos in women less than 40 years old undergoing frozen transfer cycles Inna Berin, M.D., Lawrence L. Engmann, M.D., Claudio.

Experience with a patient-friendly, mandatory, single-blastocyst transfer policy: the power of one John M. Csokmay, M.D., Micah J. Hill, D.O., Rebecca.

Krinos M. Trokoudes, M. D. , Constantinos Pavlides, M. Sc

Comprehensive chromosome screening alters traditional morphology-based embryo selection: a prospective study of 100 consecutive cycles of planned fresh.

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles2

Not all twins are monozygotic after elective single embryo transfer: analysis of 32,600 elective single embryo transfer cycles as reported to the Society.

Male age negatively impacts embryo development and reproductive outcome in donor oocyte assisted reproductive technology cycles John L. Frattarelli,

Ernesto Bosch, M. D. , Elena Labarta, M. D

Presentation transcript:

A GnRH agonist and exogenous hormone stimulation protocol has a higher live-birth rate than a natural endogenous hormone protocol for frozen-thawed blastocyst-stage embryo transfer cycles: an analysis of 1391 cycles Micah J. Hill, D.O., Kathleen A. Miller, B.S., John L. Frattarelli, M.D. Fertility and Sterility Volume 93, Issue 2, Pages 416-422 (January 2010) DOI: 10.1016/j.fertnstert.2008.11.027 Copyright © 2010 Terms and Conditions

Figure 1 Comparison of live-birth rates between the synthetic and natural cryopreserved-thawed blastocyst-stage ET cycles. The top graph represents all patients who underwent an ET (excludes cycle cancellations). The bottom graph represents all cycle starts (including cycle cancellations). Group A (n = 1391) consists of all patients. Group B (n = 211) consists of patients having a single blastocyst-stage ET. Group C (n = 859) consists of patients having two blastocyst-stage embryos transferred. Group D (n = 191) consists of patients having either one or two blastocyst-stage ETs who have additional cryopreserved blastocyst-stage embryos available. ∗Statistically significant (P<.05). Fertility and Sterility 2010 93, 416-422DOI: (10.1016/j.fertnstert.2008.11.027) Copyright © 2010 Terms and Conditions